Figure 3.
Biomarker normalization. The proportion of patients with CRP normalization (A) (CRP serum concentration levels less than normal range as per cut-off used in the corresponding institutions) and FCP normalization (B) (FCP < 250 µg/g); CRP, C-reactive protein; FCP, Fecal Calprotectin; UST, ustekinumab; anti-TNF, anti-tumor necrosis factor.